IL140992A0 - Polymer complexes of glucuronoglucanes - Google Patents

Polymer complexes of glucuronoglucanes

Info

Publication number
IL140992A0
IL140992A0 IL14099299A IL14099299A IL140992A0 IL 140992 A0 IL140992 A0 IL 140992A0 IL 14099299 A IL14099299 A IL 14099299A IL 14099299 A IL14099299 A IL 14099299A IL 140992 A0 IL140992 A0 IL 140992A0
Authority
IL
Israel
Prior art keywords
glucuronoglucanes
linear
polymer complexes
polymer
synthetic
Prior art date
Application number
IL14099299A
Other languages
English (en)
Original Assignee
Alpenstock Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpenstock Holdings Ltd filed Critical Alpenstock Holdings Ltd
Publication of IL140992A0 publication Critical patent/IL140992A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5424—Polymers characterized by specific structures/properties characterized by the charge anionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Laminated Bodies (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
IL14099299A 1998-07-21 1999-07-21 Polymer complexes of glucuronoglucanes IL140992A0 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IE980594 1998-07-21
IE980598 1998-07-21
IE980595 1998-07-21
IE980596 1998-07-21
IE980599 1998-07-21
IE980597 1998-07-21
PCT/IE1999/000067 WO2000005269A1 (en) 1998-07-21 1999-07-21 Polymer complexes of glucuronoglucanes

Publications (1)

Publication Number Publication Date
IL140992A0 true IL140992A0 (en) 2002-02-10

Family

ID=27547368

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14099299A IL140992A0 (en) 1998-07-21 1999-07-21 Polymer complexes of glucuronoglucanes

Country Status (15)

Country Link
US (6) US6743775B2 (ja)
EP (4) EP1098640A1 (ja)
JP (4) JP2002521347A (ja)
CN (1) CN1309666B (ja)
AT (1) ATE259830T1 (ja)
AU (8) AU5062099A (ja)
CA (1) CA2338141C (ja)
CZ (1) CZ301410B6 (ja)
DE (1) DE69914928T2 (ja)
ES (1) ES2216543T3 (ja)
GB (1) GB2374075B (ja)
HK (1) HK1038757A1 (ja)
IE (7) IE990615A1 (ja)
IL (1) IL140992A0 (ja)
WO (8) WO2000004907A1 (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1098640A1 (en) * 1998-07-21 2001-05-16 Alpenstock Holdings Limited Anti-ulcer composition comprising a polysaccharide containing glucuronic acid
FI20011403A (fi) * 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
DE10133546A1 (de) * 2001-07-11 2003-03-06 Petra Bastian Mischkomplexe zur Maskierung bitter schmeckender Substanzen
WO2003022887A1 (de) * 2001-09-04 2003-03-20 Heppe Gmbh Werkstoffe aus modifizierten polysacchariden und verfahren zu ihrer herstellung
WO2003068245A1 (en) * 2002-02-14 2003-08-21 Alpenstock Holdings Limited Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator
US20040153614A1 (en) * 2003-02-05 2004-08-05 Haim Bitner Tape storage emulation for open systems environments
JP2005220068A (ja) * 2004-02-05 2005-08-18 Toppan Printing Co Ltd 経口物用コーティング剤
CA2683271A1 (en) * 2004-02-20 2005-09-09 Terry Clancy System and method for authenticated detachment of product tags
US6998397B2 (en) * 2004-07-23 2006-02-14 Drebsk Comptech, Inc. Method for decreasing cholesterol level in blood
US7355235B2 (en) * 2004-12-22 2008-04-08 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor device and method for high-k gate dielectrics
DE602005019627D1 (de) 2005-03-22 2010-04-08 Ericsson Telefon Ab L M Verfahren und anordnung für auf einer dienstausführungsplattform ablaufende dienste
WO2007036920A2 (en) * 2005-09-28 2007-04-05 Alltracel Development Services Limited Therapeutic use of polyanhydroglucronic acid
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
WO2008010199A2 (en) * 2006-07-18 2008-01-24 Nanopeutics S.R.O. A nanofibre product
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
WO2008136331A1 (ja) * 2007-04-26 2008-11-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo 分岐α－グルカン及びこれを生成するα－グルコシル転移酵素とそれらの製造方法並びに用途
ATE520811T1 (de) * 2007-06-19 2011-09-15 Procter & Gamble Vliesnetze aus behandelten fasern
US10639008B2 (en) 2009-10-08 2020-05-05 C. R. Bard, Inc. Support and cover structures for an ultrasound probe head
US11103213B2 (en) 2009-10-08 2021-08-31 C. R. Bard, Inc. Spacers for use with an ultrasound probe
US8668899B2 (en) 2009-11-13 2014-03-11 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
WO2011119232A2 (en) 2010-03-23 2011-09-29 Oewaves, Inc. Optical gyroscope sensors based on optical whispering gallery mode resonators
US9474269B2 (en) 2010-03-29 2016-10-25 The Clorox Company Aqueous compositions comprising associative polyelectrolyte complexes (PEC)
US20110236582A1 (en) 2010-03-29 2011-09-29 Scheuing David R Polyelectrolyte Complexes
US9309435B2 (en) 2010-03-29 2016-04-12 The Clorox Company Precursor polyelectrolyte complexes compositions comprising oxidants
EP2575907B1 (en) 2010-06-03 2015-07-29 Hemcon Medical Technologies (IP) Limited A surgical gel system
JP5812537B2 (ja) * 2010-11-05 2015-11-17 江崎グリコ株式会社 アミノ糖含有グルカン、その製造法および利用
US9005635B2 (en) 2011-03-01 2015-04-14 The Procter & Gamble Company Articles and processes for making a porous disintegratable solid substrate for personal health care applications
USD724745S1 (en) 2011-08-09 2015-03-17 C. R. Bard, Inc. Cap for an ultrasound probe
USD699359S1 (en) 2011-08-09 2014-02-11 C. R. Bard, Inc. Ultrasound probe head
US9211107B2 (en) 2011-11-07 2015-12-15 C. R. Bard, Inc. Ruggedized ultrasound hydrogel insert
US10820885B2 (en) 2012-06-15 2020-11-03 C. R. Bard, Inc. Apparatus and methods for detection of a removable cap on an ultrasound probe
CA2914610C (en) 2013-03-13 2022-08-02 University Of Maryland Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
CN103224575A (zh) * 2013-04-27 2013-07-31 武汉大学 一种丙烯酰胺甲壳素及其制备方法
CN103204957B (zh) * 2013-04-27 2015-11-11 武汉大学 一种温敏性甲壳素及其制备方法
WO2015042104A1 (en) * 2013-09-17 2015-03-26 Biolife, L.L.C. Improved adaptive devices and methods for endoscopic wound closures
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
US8975220B1 (en) 2014-08-11 2015-03-10 The Clorox Company Hypohalite compositions comprising a cationic polymer
RU2578035C1 (ru) * 2014-11-05 2016-03-20 Общество с ограниченной ответственностью Малое научно-производственное предприятие "Старт-Фарм" Противохеликобактерное бактерицидное средство и способ его получения
CN104839198B (zh) * 2015-03-20 2017-05-10 山西省农业科学院植物保护研究所 一种用于防治桃小食心虫的温敏型农药缓释剂
CZ307155B6 (cs) * 2016-12-16 2018-02-07 Synthesia, A. S. Supramolekulární komplex oxycelulózové matrice s antracyklinovým cytostatikem s postupným uvolňováním antracyklinového cytostatika a jeho použití
RU194279U1 (ru) * 2019-07-16 2019-12-05 Владимир Владимирович Гришин Гранулы для остановки кровотечений различной степени тяжести
EP4306138A1 (en) * 2021-03-12 2024-01-17 Artisan Lab Co., Ltd. Hemostatic material

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB709684A (en) * 1951-09-21 1954-06-02 Nyma Kunstzijdespinnerij Nv Improvements in or relating to the oxidation of cellulose
FR2167219A1 (en) * 1972-01-10 1973-08-24 Faure Laboratoires Polyuronic mucilage from cassia absus - for treatment of peptic ulcer and gastric mucosal disorders
GB1457885A (en) 1973-03-29 1976-12-08 Gallaher Ltd Oxidation of cellulose
JPS5114179A (ja) * 1974-07-26 1976-02-04 Fuji Photo Film Co Ltd
JPS54148090A (en) * 1978-05-11 1979-11-19 Ajinomoto Co Inc Peroral cholesterol-depressant
CS235108B1 (cs) * 1981-06-24 1985-05-15 Ivan Blazicek Hemostatická hmota
DE3332429T1 (de) * 1982-02-22 1984-01-26 Belorusskij naučno-issledovatel'skij sanitarno-gigieničeskij institut, 220012 Minsk Arzneipraeparat mit antinikotinwirkung und verfahren zu seiner herstellung
JPS5938204A (ja) * 1982-08-27 1984-03-02 Showa Sangyo Kk 多糖類及びその製法並びにそれを有効成分とする降コレステロ−ル剤
CS235470B1 (cs) * 1982-10-19 1985-05-15 Maxmilian Mozisek Hemostatické hemoroidálnf čípk
JPS59163323A (ja) * 1983-03-08 1984-09-14 Showa Sangyo Kk 動脈硬化性疾患防止剤
CS242920B1 (cs) * 1984-02-16 1986-05-15 Jiri Briestensky Sorbent na bázi oxidované celulózy a způsob jeho výroby
JPS6164701A (ja) * 1984-09-06 1986-04-03 Meito Sangyo Kk カチオン化デキストラン誘導体とポリウロン酸の高分子電解質錯体及びその利用
CA1286299C (en) * 1985-05-13 1991-07-16 Johji Yamahara 3,4-dihydrobenzopyran derivatives and medicinal uses thereof
JPS61293913A (ja) * 1985-06-21 1986-12-24 Kuraray Co Ltd 肝臓疾患治療剤
CS253042B1 (en) * 1985-09-25 1987-10-15 Maxmilian Mozisek Haemostatical material
JPS6396155A (ja) * 1986-10-13 1988-04-27 Kuraray Co Ltd 新規なテルペン化合物およびこれを含有する抗炎症剤
JPS646260A (en) * 1987-06-27 1989-01-10 Yamasa Shoyu Kk 6-iodoacyclouridine derivative
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
JPH02221224A (ja) * 1989-02-22 1990-09-04 Tatsuaki Yamaguchi 尿素吸着剤の製造方法
CS276813B6 (cs) * 1990-05-10 1992-08-12 Leciva Přípravek pro léčení hemoroidů
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5166137A (en) 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
IT1263755B (it) * 1991-09-16 1996-08-29 Fidia Spa Uso di esteri della colina con polisaccaridi acidi come agenti antiulcera e gastroprotettivi
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
JPH0662425B2 (ja) * 1992-12-02 1994-08-17 生化学工業株式会社 ヒアルロン酸含有血中脂質低下剤
AU8129894A (en) * 1993-11-01 1995-05-23 Alpha-Beta Technology, Inc. Derivatized polysaccharide bile acid sequestrant for reducing cholesterol
RU2136319C1 (ru) 1993-12-23 1999-09-10 Джонсон энд Джонсон Медикал, Инк. Биоабсорбируемое хирургическое гемостатическое средство и способ его получения (варианты)
JPH07188038A (ja) * 1993-12-28 1995-07-25 Kao Corp 高脂血症治療剤
JPH07309766A (ja) * 1994-05-20 1995-11-28 Sekisui Chem Co Ltd コレステロール低下剤
WO1997022308A1 (de) * 1995-12-18 1997-06-26 Degussa Aktiengesellschaft Medizinisches implantat
US5593682A (en) * 1995-12-29 1997-01-14 Eastman Chemical Company Skin treating composition
GB2314842B (en) * 1996-06-28 2001-01-17 Johnson & Johnson Medical Collagen-oxidized regenerated cellulose complexes
WO1998033822A1 (en) * 1997-01-30 1998-08-06 Alpenstock Holdings Limited Cellulose derivatives
JP4132125B2 (ja) * 1997-04-16 2008-08-13 タカラバイオ株式会社 ヘリコバクター・ピロリ接着阻害剤
EP1098640A1 (en) * 1998-07-21 2001-05-16 Alpenstock Holdings Limited Anti-ulcer composition comprising a polysaccharide containing glucuronic acid

Also Published As

Publication number Publication date
IE990618A1 (en) 2000-05-03
US20060275251A1 (en) 2006-12-07
DE69914928T2 (de) 2004-12-16
HK1038757A1 (zh) 2002-03-28
JP2002521392A (ja) 2002-07-16
GB0030730D0 (en) 2001-01-31
JP2002521338A (ja) 2002-07-16
EP1098663A1 (en) 2001-05-16
IE990613A1 (en) 2000-05-03
CN1309666A (zh) 2001-08-22
US20010003742A1 (en) 2001-06-14
WO2000005269A1 (en) 2000-02-03
GB2374075A (en) 2002-10-09
IE990617A1 (en) 2000-05-03
US6596791B2 (en) 2003-07-22
WO2000004891A2 (en) 2000-02-03
IE990615A1 (en) 2000-05-03
EP1115747A1 (en) 2001-07-18
AU5061999A (en) 2000-02-14
DE69914928D1 (de) 2004-03-25
GB2374075B (en) 2003-09-10
WO2000004877A1 (en) 2000-02-03
AU5061899A (en) 2000-02-14
WO2000004925A1 (en) 2000-02-03
EP1098654A1 (en) 2001-05-16
ATE259830T1 (de) 2004-03-15
WO2000004939A1 (en) 2000-02-03
IE990616A1 (en) 2000-05-03
CZ301410B6 (cs) 2010-02-17
WO2000004907A1 (en) 2000-02-03
IE990614A1 (en) 2000-05-03
AU5062099A (en) 2000-02-14
WO2000004937A1 (en) 2000-02-03
CZ2001230A3 (en) 2001-06-13
US20040106730A1 (en) 2004-06-03
WO2000004891A3 (en) 2001-04-12
AU758383B2 (en) 2003-03-20
IE990638A1 (en) 2000-05-03
JP2002521347A (ja) 2002-07-16
AU5062499A (en) 2000-02-14
AU5062299A (en) 2000-02-14
US6743775B2 (en) 2004-06-01
ES2216543T3 (es) 2004-10-16
WO2000004882A1 (en) 2000-02-03
US20010006957A1 (en) 2001-07-05
AU5062199A (en) 2000-02-14
EP1115747B1 (en) 2004-02-18
CN1309666B (zh) 2011-07-27
IE990611A1 (en) 2000-05-03
AU5062399A (en) 2000-02-14
CA2338141A1 (en) 2000-02-03
US6706695B2 (en) 2004-03-16
US20030040487A1 (en) 2003-02-27
EP1098640A1 (en) 2001-05-16
US20010012837A1 (en) 2001-08-09
JP2002521327A (ja) 2002-07-16
CA2338141C (en) 2009-10-27
AU5061799A (en) 2000-02-14

Similar Documents

Publication Publication Date Title
GB0030730D0 (en) Polymer complexes of glucuronoglucanes
EP0537292A4 (en) Water insoluble derivatives of hyaluronic acid
AU7097094A (en) Carbohydrate-modified polymer conjugates with erythropoietic activity
NZ296452A (en) Conjugates of bdnf or nt-3 and at least one water-soluble polymer
AP1556A (en) Novel inulin fractions, process for preparing same, and food products containing said inulin fractions.
CA2285383A1 (en) Glycosaminoglycans having high antithrombotic activity
ZA983626B (en) Pharmaceutical compositions against peptic ulcer
WO1994026263A3 (en) Use of a transition metal complex for the treatment of septic shock
DK0699689T3 (da) Forgrenet polysaccharid, mikroorganisme, der producerer dette, samt præparater indeholdende disse
CA2046345A1 (en) Functional food
CA2314716A1 (en) Modified polysaccharides exhibiting altered biological recognition
GB9013779D0 (en) Self-lubricating,two stage variable compressor
AU1807097A (en) 1:2 chromium complexes, their production and use
ZA200006725B (en) Novel furylphosphines and organometallic complexes containing them.
AU2135201A (en) Iron olefin copolymerization catalyst
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
EP1038532A4 (en) IMMUNO MODULATOR AND PHARMACEUTICAL COMPOSITIONS WITH ANTITUM PROPERTIES, AND A FOOD ADDITIVE
MY113423A (en) Substituted thiophenesulfonylureas and -thioureas processes for their preparation, their use as amedicament or diagnostic, and medicament contiaining them
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь
IT1269986B (it) Composizioni farmaceutiche a base di melatonina
AUPN775096A0 (en) Calcium dietary supplement with added vitamins C, D and soluble dietary fibre known as Culture Plus
ITFI930270A0 (it) Struttura di catena,in particolare ma non esclusivamente,per la realizzazione di catene ornamentali.
MX9705119A (es) Interferona modificada quimicamente.
GR960100275A (el) Αναμικτηρας πολλαπλων κατευθυνσεων.
IE880917L (en) Blending microbial polysaccharide and synthetic polymer

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees